After treating RCC cells with 2′-deoxy-5-azacytidine (5-Aza), a potent inhibitor of DNMTs, we observed a remarkable augmentation of UBB expression (Fig. 5C, D). The gene discussed is UBB; the disease is renal cell carcinoma.